ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It

September 19, 1980